Should β-Blockers Be Used in Patients with Heart Failure and Atrial Fibrillation?

Clinical Therapeutics

Volumn 37, Issue 10, 2015, Pages 2215-2224

  Mareev, Yura ^a   Cleland, John G F ^a  

^a HAREFIELD HOSPITAL   (United Kingdom)

Author keywords

atrial fibrillation; beta blockers; heart failure; prognosis; rate control

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ATRIAL FIBRILLATION; BRADYCARDIA; CARDIOVASCULAR MORTALITY; DRUG EFFECT; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RATE; HEART RHYTHM; HOSPITALIZATION; HUMAN; META ANALYSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SINUS RHYTHM; TREATMENT OUTCOME; CARDIOVASCULAR DISEASES; COMPLICATION; META ANALYSIS (TOPIC); PATHOPHYSIOLOGY;

ADRENERGIC BETA-ANTAGONISTS; ATRIAL FIBRILLATION; CARDIOVASCULAR DISEASES; HEART FAILURE; HOSPITALIZATION; HUMANS; META-ANALYSIS AS TOPIC;

EID: 84945456912     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2015.08.017     Document Type: Review

References (63)

1. A.U. Khand, A.C. Rankin, G.C. Kaye, and J.G. Cleland Systematic review of the management of atrial fibrillation in patients with heart failure Eur Heart J 21 2000 614 632
2. K. Guha, and T. McDonagh Heart failure epidemiology: European perspective Curr Cardiol Rev 9 2013 123 127
3. E. Anter, M. Jessup, and D.J. Callans Atrial fibrillation and heart failure: Treatment considerations for a dual epidemic Circulation 119 2009 2516 2525
4. A.U. Khand, J.G.F. Cleland, and P.C. Deedwania Prevention of and medical therapy for atrial arrhythmias in heart failure Heart Fail Rev 7 2002 267 283
5. J.G.F. Cleland, R. Shelton, N. Nikitin, and et al. Prevalence of markers of heart failure in patients with atrial fibrillation and the effects of ximelagatran compared to warfarin on the incidence of morbid and fatal events: a report from the SPORTIF III and V trials Eur J Heart Fail 9 2007 730 739
6. J.G.F. Cleland, K. Swedberg, F. Follath, and et al. The EuroHeart Failure survey programme - a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis Eur Heart J 24 2003 442 463
7. D. Castagno, H. Skali, M. Takeuchi, and et al. Association of heart rate and outcomes in a broad spectrum of patients with chronic heart failure: Results from the CHARM (Candesartan in Heart Failure: Assessment of Reduction in Mortality and morbidity) program J Am Coll Cardiol 59 2012 1785 1795
8. G.Y. Lip, C. Laroche, M.I. Popescu, L.H. Rasmussen, G.A. Vitali-Serdoz Dan, Z. Kalarus, H.J. Crijns, M.M. Oliveira, L. Tavazzi, A.P. Maggioni, and G. Boriani Heart failure in patients with atrial fibrillation in Europe: a report from the EURObservational Research Programme Pilot survey on Atrial Fibrillation Eur J Heart Fail 17 6 2015 570 582
9. M.J. Lenzen, W.J.M. Scholte op Reimer, E. Boersma, and et al. Differences between patients with a preserved and a depressed left ventricular function: a report from the EuroHeart Failure Survey Eur Heart J 25 2004 1214 1220
10. D. Kotecha, J. Holmes, H. Krum, and et al. Efficacy of β blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis Lancet 384 2014 2235 2243
11. D.J. van Veldhuisen, A. Cohen-Solal, M. Böhm, and et al. Beta-Blockade With Nebivolol in Elderly Heart Failure Patients With Impaired and Preserved Left Ventricular Ejection Fraction. Data From SENIORS (Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart Failure) J Am Coll Cardiol 53 2009 2150 2158
12. J.J.V. McMurray, and D.J. van Veldhuisen β Blockers, Atrial Fibrillation, and Heart Failure Lancet 384 2014 2181 2183
13. B.A. Mulder, D.J. van Veldhuisen, H.J.G.M. Crijns, and et al. Effect of nebivolol on outcome in elderly patients with heart failure and atrial fibrillation: insights from SENIORS Eur J Heart Fail 14 2012 1171 1178
14. I.A. Nasr, A. Bouzamondo, J.-S. Hulot, and et al. Prevention of atrial fibrillation onset by beta-blocker treatment in heart failure: a meta-analysis Eur Heart J 28 2007 457 462
15. K. Swedberg, L.G. Olsson, A. Charlesworth, and et al. Prognostic relevance of atrial fibrillation in patients with chronic heart failure on long-term treatment with beta-blockers: Results from COMET Eur Heart J 26 2005 1303 1308
16. H. Gong, H. Sun, W.J. Koch, and et al. Specific beta(2)AR blocker ICI 118,551 actively decreases contraction through a G(i)-coupled form of the beta(2)AR in myocytes from failing human heart Circulation 105 2002 2497 2503
17. S.D.R. Thackray, J.M. Ghosh, G.A. Wright, and et al. The effect of altering heart rate on ventricular function in patients with heart failure treated with beta-blockers Am Heart J 152 2006 713.e9-13
18. M. Böhm, K. Swedberg, M. Komajda, and et al. Heart rate as a risk factor in chronic heart failure (SHIFT): The association between heart rate and outcomes in a randomised placebo-controlled trial Lancet 376 2010 886 894
19. F.A. McAlister, N. Wiebe, J.A. Ezekowitz, and et al. Meta-analysis: beta-blocker dose, heart rate reduction, and death in patients with heart failure Ann Intern Med 150 2009 784 794
20. D. Cullington, K.M. Goode, J. Zhang, and et al. Is heart rate important for patients with heart failure in atrial fibrillation? JACC Heart Fail 2 2014 213 220
21. M. Böhm, A.-C. Perez, P.S. Jhund, and et al. Relationship between heart rate and mortality and morbidity in the irbesartan patients with heart failure and preserved systolic function trial (I-Preserve) Eur J Heart Fail 16 2014 778 787
22. K. Swedberg, M. Komajda, M. Böhm, and et al. Ivabradine and outcomes in chronic heart failure (SHIFT): A randomised placebo-controlled study Lancet 376 2010 875 885
23. J.S. Borer, M. Böhm, I. Ford, and et al. Effect of ivabradine on recurrent hospitalization for worsening heart failure in patients with chronic systolic heart failure: the SHIFT Study Eur Heart J 33 2012 2813 2820
24. R.I.R. Martin, O. Pogoryelova, M.S. Koref, and et al. Atrial fibrillation associated with ivabradine treatment: meta-analysis of randomised controlled trials Heart 100 2014 1506 1510
25. The Digitalis Investigation Group, The effect of digoxin on mortality and morbidity in patients with heart failure N Engl J Med 336 1997 525 533
26. M. Rienstra, I.C. Van Gelder, M.P. Van Den Berg, and et al. A comparison of low versus high heart rate in patients with atrial fibrillation and advanced chronic heart failure: Effects on clinical profile, neurohormones and survival Int J Cardiol 109 2006 95 100
27. I.C. Van Gelder, H.F. Groenveld, H.J.G.M. Crijns, and et al. Lenient versus strict rate control in patients with atrial fibrillation N Engl J Med 362 2010 1363 1373
28. B.A. Mulder, D.J. Van Veldhuisen, H.J.G.M. Crijns, and et al. Lenient vs. strict rate control in patientswith atrial fibrillation and heart failure: A post-hoc analysis of the RACE 2 study Eur J Heart Fail 15 2013 1311 1318
29. D.M. Clark, V.J. Plumb, A.E. Epstein, and G.N. Kay Hemodynamic effects of an irregular sequence of ventricular cycle lengths during atrial fibrillation J Am Coll Cardiol 30 1997 1039 1045
30. A.T.M. Gosselink, P.K. Blanksma, H.J.G.M. Crijns, and et al. Left ventricular beat-to-beat performance in atrial fibrillation: Contribution of Frank-Starling mechanism after short rather than long RR intervals J Am Coll Cardiol 26 1995 1516 1521
31. P. Pellicori, J. Zhang, E. Lukaschuk, and et al. Left atrial function measured by cardiac magnetic resonance imaging in patients with heart failure: clinical associations and prognostic value Eur Heart J 36 2015 733 742
32. M. Rienstra, K. Damman, B.A. Mulder, and et al. Beta-blockers and outcome in heart failure and atrial fibrillation: a meta-analysis JACC Heart Fail 1 2013 21 28
33. P.A. Poole-Wilson, K. Swedberg, J.G.F. Cleland, and et al. Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial Lancet 362 2003 7 13
34. A.U. Khand, A.C. Rankin, W. Martin, and et al. Carvedilol Alone or in Combination with Digoxin for the Management of Atrial Fibrillation in Patients with Heart Failure? J Am Coll Cardiol 42 2003 1944 1951
35. P.E. Bloch Thomsen, C. Jons, M.J.P. Raatikainen, and et al. Long-term recording of cardiac arrhythmias with an implantable cardiac monitor in patients with reduced ejection fraction after acute myocardial infarction: the Cardiac Arrhythmias and Risk Stratification After Acute Myocardial Infarction (CARISMA) study Circulation 122 2010 1258 1264
36. A.C.H. Ruwald, P.E. Bloch Thomsen, U. Gang, and et al. New-onset atrial fibrillation predicts malignant arrhythmias in post-myocardial infarction patients - A Cardiac Arrhythmias and RIsk Stratification after acute Myocardial infarction (CARISMA) substudy Am Heart J 166 2013 855 863.e3
37. U.J.O. Gang, C. Jøns, R.M. Jørgensen, and et al. Heart rhythm at the time of death documented by an implantable loop recorder Europace 12 2010 254 260
38. G.C. Grönefeld, O. Mauss, Y.G. Li, and et al. Association between atrial fibrillation and appropriate implantable cardioverter defibrillator therapy: results from a prospective study J Cardiovasc Electrophysiol 11 2000 1208 1214
39. N.V. Kurlykina, A.V. Pevzner, A.I. Litvin, and et al. [Treatment of patients with long nocturnal asystoles and obstructive sleep apnea syndrome by creating continuous positive air pressure in the upper respiratory tract] Kardiologiia 49 2009 36 42
40. J.G. Cleland, B.M. Massie, and M. Packer Sudden death in heart failure: vascular or electrical? Eur J Heart Fail 1 1999 41 45
41. P. Santangeli, L. Di Biase, A. Dello Russo, and et al. Meta-analysis: age and effectiveness of prophylactic implantable cardioverter-defibrillators Ann Intern Med 153 2010 592 599
42. A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure N Engl J Med 344 2001 1659 1667
43. D.P. Kao, G. Davis, R. Aleong, and et al. Effect of bucindolol on heart failure outcomes and heart rate response in patients with reduced ejection fraction heart failure and atrial fibrillation Eur J Heart Fail 15 2013 324 333
44. E. Black-Maier, B.A. Steinberg, and J.P. Piccini Bucindolol hydrochloride in atrial fibrillation and concomitant heart failure Expert Rev Cardiovasc Ther 13 2015 627 636
45. E.L. Ang, W.L. Chan, J.G. Cleland, and et al. Placebo controlled trial of xamoterol versus digoxin in chronic atrial fibrillation Br Heart J 64 1990 256 260
46. M.O. Sweeney, A.S. Hellkamp, K.A. Ellenbogen, and et al. Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction Circulation 107 2003 2932 2937
47. R.N. Doshi, E.G. Daoud, C. Fellows, and et al. Left ventricular-based cardiac stimulation post AV nodal ablation evaluation (The PAVE study) J Cardiovasc Electrophysiol 16 2005 1160 1165
48. M. Brignole, G.L. Botto, L. Mont, and et al. Predictors of clinical efficacy of 'Ablate and Pace' therapy in patients with permanent atrial fibrillation Heart 98 2012 297 302
49. J.G.F. Cleland, F. Keshavarzi, P. Pellicori, and B. Dicken Case selection for cardiac resynchronization in atrial fibrillation Heart Fail Clin 9 ix 2013 461 474
50. A.-J. Ouyang, Y.-N. Lv, H.-L. Zhong, and et al. Meta-analysis of digoxin use and risk of mortality in patients with atrial fibrillation Am J Cardiol 115 2015 901 906
51. M.G. Whitbeck, R.J. Charnigo, P. Khairy, and et al. Increased mortality among patients taking digoxin - analysis from the AFFIRM study Eur Heart J 34 2013 1481 1488
52. M. Gheorghiade, G.C. Fonarow, D.J. van Veldhuisen, and et al. Lack of evidence of increased mortality among patients with atrial fibrillation taking digoxin: findings from post hoc propensity-matched analysis of the AFFIRM trial Eur Heart J 34 2013 1489 1497
53. E. Jorge, R. Baptista, H. Martins, and et al. Digoxin in advanced heart failure patients: A question of rhythm Rev Port Cardiol 32 2013 303 310
54. Oliver Ziff GYL, Dipak Kotecha, Monica Samra, et al.Digoxin - friend or foe? A Comprehensive review of digoxin use and mortality, abstracts in British Cardiology Society, 2015. [Online]. http://www.bcs.com/abstracts3/marker-view.asp?AbstractID=1230. [Accessed: 2015].
55. D.L. Packer, J.M. Prutkin, A.S. Hellkamp, and et al. Impact of implantable cardioverter-defibrillator, amiodarone, and placebo on the mode of death in stable patients with heart failure: analysis from the sudden cardiac death in heart failure trial Circulation 120 2009 2170 2176
56. L. Køber, C. Torp-Pedersen, J.J.V. McMurray, and et al. Increased mortality after dronedarone therapy for severe heart failure N Engl J Med 358 2008 2678 2687
57. M. Talajic, P. Khairy, S. Levesque, and et al. Maintenance of sinus rhythm and survival in patients with heart failure and atrial fibrillation J Am Coll Cardiol 55 2010 1796 1802
58. R.J. Shelton, A.L. Clark, K. Goode, and et al. A randomised, controlled study of rate versus rhythm control in patients with chronic atrial fibrillation and heart failure: (CAFE-II Study) Heart 95 2009 924 930
59. D. Roy, M. Talajic, S. Nattel, and et al. Rhythm control versus rate control for atrial fibrillation and heart failure N Engl J Med 358 2008 2667 2677
60. S.N. Singh, J. Poole, J. Anderson, and et al. Role of amiodarone or implantable cardioverter/defibrillator in patients with atrial fibrillation and heart failure Am Heart J 152 2006 974.e7-11
61. Luigi Di Biase AN, Prasant Mohanty, Sanghamitra Mohanty, et al., Ablation vs. amiodarone for treatment of persistent atrial fibrillation in patients with congestive heart failure and an implanted device: Results from the AATAC multicenter randomized trial, American College of Cardiology 2015 Scientific Sessions; March 16, 2015; San Diego, CA. Abstract 408-08, 2015. [Online]. http://www.abstractsonline.com/pp8/#!/3658/presentation/37598. [Accessed: 21-Jun-2015].
62. N.F. Marrouche, and J. Brachmann Catheter ablation versus standard conventional treatment in patients with left ventricular dysfunction and atrial fibrillation (CASTLE-AF) - study design Pacing Clin Electrophysiol 32 Aug. 2009 987 994
63. W.K. Laskey, I. Alomari, M. Cox, and et al. Heart Rate at Hospital Discharge in Patients With Heart Failure Is Associated With Mortality and Rehospitalization J Am Heart Assoc 4 2015 e001626-e001626, http://jaha.ahajournals.org/content/4/4/e001626